All material subject to strictly enforced copyright laws. © 2022 Euromoney Institutional Investor PLC group
Corporate Bonds

GSK’s £1.4bn breaks coupon records as 2012 ends on a high

GlaxoSmithKline, the UK pharmaceutical company, launched its first sterling bonds this week for nearly five years, achieving strong demand and raising £1.4bn in the second biggest corporate issue of the year in the currency.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Take a Free Trial or Login
We use cookies to provide a personalized site experience.
By continuing to use & browse the site you agree to our Privacy Policy.
I agree